tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Stock Investors

151 Followers
Based on 728,988 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RNAZ
On average, investors allocate 0.00% of their portfolios to RNAZ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RNAZ

1.3%
Last 7
Days
5.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RNAZ, out of 728,988 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RNAZ Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$14.84
Based on the activity of 13,687 investors who made their portfolios public
The table shows changes in RNAZ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RNAZ Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.74%
-1.51%
-0.24%
2.02B
Financial
ChargePoint Holdings
3.92%
-0.98%
-7.42%
592.70M
Consumer Cyclical
Marathon Digital Holdings
5.39%
-0.80%
-3.86%
4.14B
Financial
Coinbase Global
8.20%
-0.41%
-2.39%
51.79B
Financial
Airbnb
4.76%
-0.65%
-4.49%
103.35B
Consumer Cyclical
AMC Entertainment
5.42%
-1.20%
-6.80%
785.54M
Communication Services
UiPath
3.53%
-0.55%
-2.02%
10.88B
Technology
DraftKings
7.19%
-0.88%
-3.40%
36.58B
Consumer Cyclical
GE Aerospace
5.53%
+0.62%
+6.08%
170.19B
Industrials
Plug Power
4.90%
-0.90%
-6.61%
1.87B
Industrials
Based on the activity of 728,988 active portfolios
Open your Smart Portfolio

RNAZ Investor Analysis

RNAZ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
53.3%
of RNAZ holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
RNAZ investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
20.0%
of RNAZ holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
RNAZ investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.7%
of RNAZ holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of RNAZ stock investors
See who invests in RNAZ according to age group and performance.

FAQ

How many retail Investors hold RNAZ?
<0.1% of TipRanks' retail investors hold RNAZ in their portfolios.
    What is RNAZ Investor Sentiment?
    RNAZ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RNAZ in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of RNAZ in the last 7 days.
        What percentage of retail investors changed their holding of RNAZ in the last 30 days?
        ▼ 5.4% of TipRanks' retail investors changed their holding of RNAZ in the last 30 days.
          What is the average age of retail investors who hold RNAZ?
          The average age of RNAZ Holders is under 35.
            What other stocks have RNAZ investors also bought?
            RNAZ Investors also bought RIOT, CHPT, MARA, COIN, ABNB, AMC, PATH, DKNG, GE, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis